Table 3 Demographic and Clinical Characteristics of CHR-P Subgroups
|  | APS & BS | APS | BS | df | K2/H/χ2 | p |
|---|---|---|---|---|---|---|
Number of participants | 64 | 45 | 25 | Â | Â | Â |
Female participants, n (%) | 44 (68.8) | 34 (75.6) | 15 (60.0) | 2 | χ2 = 2 | 0.4 |
Age at baseline, median (range) | 21 (16–34) | 19 (16–32) | 21 (17–31) | 2 | H = 4 | 0.1 |
Age at onset, median (range) | 17 (5–29) | 18 (4–31) | 17 (5–25) | 2 | H = 2 | 0.3 |
Years in education, median (range) | 15 (10–26) | 14 (8–21) | 15 (11–18) | 2 | H = 6 | 0.04 |
UK citizen, N (%) | 46 (71.9) | 31 (68.9) | 20 (80.0) | 2 | χ2 = 0.8 | 0.7 |
ARMS | ||||||
 APS criteria, n = 109 (81.34%) | 64 | 45 | – | 1 | χ2 = 0.00 | 1.0 |
 BLIPS criteria | 0 | 0 | – |  |  |  |
 Severity score, mean (range) | 16.31 (1–30) | 15.31 (9–25) | – | 1 | K2 = 0.36 | 0.549 |
COPER | ||||||
 Criteria, n = 88 (61.94%) a | 61 | – | 27 |  | χ2 = 1.17 | 0.280 |
 Sum score, mean (range) | 4.07 (3–6) | – | 4.05 (3–6) |  | K2 = 2.85 | 0.092 |
COGDIS | ||||||
 Criteria, n = 57 (32.09%)a | 39 | – | 18 |  | χ2 = 0.70 | 0.403 |
 Sum score, mean (range) | 4.35 (3–6) | – | 4.13 (3–6) |  | K2 = 0.18 | 0.669 |
Mean duration (SD), in months | ||||||
 APS | 46 (45) | 39 (54) | – |  | F = 0.54 | 0.46 |
 BS | 54 (45) | – | 48 (43) |  | F = 0.38 | 0.54 |
Median duration (range), in months | ||||||
 APS | 37 (1–226) | 12 (2–246) | – |  | H = 3 | 0.08 |
 BS | 44 (1–180) | – | 37 (3–187) |  | H = 0.6 | 0.4 |
GAF, median (range) | 55 (21–95) | 57 (21–86) | 62 (34–95) |  | H = 3 | 0.2 |
GF: Role, median (range) | 8 (4–9) | 8 (4–9) | 8 (6–9) |  | H = 2 | 0.4 |
GF: Social, median (range) | 8 (5–9) | 8 (5–9) | 8 (6–10) |  | H = 0.8 | 0.7 |
Current medication, n (%) | ||||||
 No medication | 28 (43.8) | 23 (51.1) | 12 (48.0) | 2 | χ2 = 0.5 | 0.8 |
 Anti-psychotic | 1 (1.6) | 1 (2.2) | 0 | 2 | χ2 = 0.5 | 0.8 |
 Mood stabiliser | 0 | 0 | 1 (4.0) | 2 | χ2 = 4 | 0.1 |
 Anti-depressant | 16 (25.0) | 11 (24.4) | 3 (12.0) | 2 | χ2 = 2 | 0.4 |
 Anti-convulsant | 0 | 0 | 1 (4.0) | 2 | χ2 = 4 | 0.1 |
 Other | 9 (14.1) | 3 (6.7) | 3 (12.0) | 2 | χ2 = 2 | 0.5 |
 Multiple | 9 (14.1) | 7 (15.6) | 5 (20.0) | 2 | χ2 = 0.4 | 0.8 |
Lifetime diagnosis, n (%) | ||||||
 No diagnosis | 5 (7.8) | 3 (6.7) | 4 (16.0) | 2 | χ2 = 2 | 0.3 |
 Anxiety disorder | 45 (70.3) | 32 (71.1) | 12 (48.0) | 2 | χ2 = 3 | 0.2 |
 Mood disorders | 57 (89.1) | 27 (60.0) | 12 (48.0) |  | χ2 = 4 | 0.1 |
 Eating disorders | 6 (9.4) | 6 (13.3) | 1 (4.0) |  | χ2 = 1 | 0.5 |
 Alcohol dependence/abuse | 20 (31.3) | 14 (31.1) | 6 (24.0) |  | χ2 = 0.2 | 0.9 |
 Substance dependence/abuse | 7 (10.9) | 11 (24.4) | 3 (12.0) |  | χ2 = 4 | 0.2 |
Suicidality n (%) | ||||||
 Suicidality | 35 (20.0) | 24 (45.8) | 13 (23.1) |  | χ2 = 0.1 | 0.9 |